Literature DB >> 17217055

TRPC7.

T Numaga1, M Wakamori, Y Mori.   

Abstract

Canonical transient receptor potential7 (TRPC7) is the seventh identified member of the mammalian TRPC channel family, comprising nonselective cation channels activated through the phospholipase C (PLC) signaling pathway. TRPC7 is directly activated by diacylglycerol (DAG), one of the PLC products, having high sequence homologywith TRPC3 and TRPC6, which are also activated by DAG. TRPC7 shows unique properties of activation, such as constitutive activity and susceptibility to negative regulation by extracellular Ca2+. Although the physiological importance of TRPC7 in the native environment remains elusive, TRPC7 would play important roles in Ca2+ signaling pathway through these characteristic features.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17217055     DOI: 10.1007/978-3-540-34891-7_8

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  6 in total

Review 1.  Transient receptor potential canonical 7: a diacylglycerol-activated non-selective cation channel.

Authors:  Xuexin Zhang; Mohamed Trebak
Journal:  Handb Exp Pharmacol       Date:  2014

Review 2.  When a TRP goes bad: transient receptor potential channels in addiction.

Authors:  Seth A Wescott; Manish Rauthan; X Z Shawn Xu
Journal:  Life Sci       Date:  2012-07-20       Impact factor: 5.037

Review 3.  Pharmacological modulation of diacylglycerol-sensitive TRPC3/6/7 channels.

Authors:  Christian Harteneck; Maik Gollasch
Journal:  Curr Pharm Biotechnol       Date:  2011-01-01       Impact factor: 2.837

4.  Melanotic Neuroectodermal Tumor of Infancy (MNTI) and Pineal Anlage Tumor (PAT) Harbor A Medulloblastoma Signature by DNA Methylation Profiling.

Authors:  Oscar Lopez-Nunez; Rita Alaggio; Ivy John; Andrea Ciolfi; Lucia Pedace; Angela Mastronuzzi; Francesca Gianno; Felice Giangaspero; Sabrina Rossi; Vittoria Donofrio; Giuseppe Cinalli; Lea F Surrey; Marco Tartaglia; Franco Locatelli; Evelina Miele
Journal:  Cancers (Basel)       Date:  2021-02-09       Impact factor: 6.639

5.  Monitoring TRPC7 Conformational Changes by BRET Following GPCR Activation.

Authors:  Cécile Pétigny; Audrey-Ann Dumont; Hugo Giguère; Audrey Collette; Brian J Holleran; Mircea Iftinca; Christophe Altier; Élie Besserer-Offroy; Mannix Auger-Messier; Richard Leduc
Journal:  Int J Mol Sci       Date:  2022-02-24       Impact factor: 6.208

6.  Sensory Ion Channel Candidates Inform on the Clinical Course of Pancreatic Cancer and Present Potential Targets for Repurposing of FDA-Approved Agents.

Authors:  Wenjie Shi; Chen Li; Thomas Wartmann; Christoph Kahlert; Renfei Du; Aristotelis Perrakis; Thomas Brunner; Roland S Croner; Ulf D Kahlert
Journal:  J Pers Med       Date:  2022-03-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.